Free Trial

CEL-SCI (CVM) News Today

CEL-SCI logo
$0.39 -0.01 (-2.21%)
Closing price 04:00 PM Eastern
Extended Trading
$0.39 +0.00 (+0.08%)
As of 06:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
CEL-SCI (NYSE:CVM) Coverage Initiated at StockNews.com
CEL-SCI prices $5M public offering at 31c per share
CEL-SCI prices $5 million offering
CEL-SCI Prices Public Offering Of 16.13 Mln Shares At $0.31/shr
CEL-SCI Announces Pricing of $5 Million Public Offering
CVM: CRO Selected for Registrational Trial
CEL-SCI files to sell 1M shares of common stock for holders
Upstream Bio Inc.
CEL-SCI Co. stock logo
CEL-SCI (NYSE:CVM) Trading Down 3.8% - Here's What Happened
CEL-SCI (NYSE:CVM) Stock Price Down 3.8% - Time to Sell?
CVM Oct 2024 2.000 call
CVM Jan 2025 1.500 call
CVM Sep 2024 1.500 call
CVM Oct 2024 1.500 call
CVM Apr 2025 1.000 put
CVM Oct 2024 0.500 call (CVM241018C00000500)
CVM Oct 2024 1.500 put (CVM241018P00001500)
CVM Sep 2024 1.000 call
Principal Investment Grd Corp Actv ETF (IG)
Biomotion Sciences.
3 Penny Stocks to Watch Now, 7/30/24
CEL-SCI Announces Closing of $10.8 Million Offering
(SANSTAR.BO)
CEL-SCI Co. stock logo
Stock Traders Purchase High Volume of Call Options on CEL-SCI (NYSE:CVM)
CEL-SCI Co. (NYSE:CVM - Get Free Report) was the target of unusually large options trading activity on Friday. Traders acquired 2,966 call options on the stock. This is an increase of approximately 986% compared to the typical daily volume of 273 call options.
CEL-SCI Announces Pricing of $10.8 Million Offering
CEL-SCI Co. stock logo
CVI Holdings LLC Invests $1.68 Million in CEL-SCI Co. (NYSE:CVM)
CVI Holdings LLC purchased a new position in shares of CEL-SCI Co. (NYSE:CVM - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 878,767 shares of the company's stock, valued at approxima
Cel-Sci Corp.
CVM: Confirmatory Study Clarity
CEL-SCI Co. stock logo
CEL-SCI Co. (NYSE:CVM) Director Acquires $27,800.00 in Stock
CEL-SCI Co. (NYSE:CVM - Get Free Report) Director Robert Eugene Watson bought 20,000 shares of the firm's stock in a transaction on Wednesday, May 8th. The stock was acquired at an average cost of $1.39 per share, with a total value of $27,800.00. Following the completion of the purchase, the director now owns 24,431 shares of the company's stock, valued at approximately $33,959.09. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Get CEL-SCI News Delivered to You Automatically

Sign up to receive the latest news and ratings for CVM and its competitors with MarketBeat's FREE daily newsletter.

CVM Media Mentions By Week

CVM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CVM
News Sentiment

0.49

0.57

Average
Medical
News Sentiment

CVM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CVM Articles
This Week

2

1

CVM Articles
Average Week

Get CEL-SCI News Delivered to You Automatically

Sign up to receive the latest news and ratings for CVM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:CVM) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners